Using Quality By Design For Process Development And Scale-Up Of A Novel ALS Drug Product

Using Quality By Design For Process Development And Scale-Up Of A Novel ALS Drug Product

Using Quality By Design For Process Development And Scale-Up Of A Novel ALS Drug Product

Amylyx Pharmaceuticals社は、筋萎縮性側索硬化症（ALS）治療薬として開発中のリード化合物AMX-0035の上市を目指し、サーモフィッシャーサイエンティフィックと提携しました。

Added Date:

2022-05-21

Filters:

Filter Category	Filter Values
Specialty	Regulatory
Month	October
Capability	Logistics
Year	2021
Expert	Sanjay Konagurthu PhD
Asset Type	Case study
Region	Global
Market Category	Clinical trial services

Country Availability:

()

Gated Form:

None Set